Status:
ENROLLING_BY_INVITATION
Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
Lead Sponsor:
Peking University First Hospital
Conditions:
Primary Aldosteronism
Adrenal Tumor
Eligibility:
All Genders
18+ years
Brief Summary
The main goal of this study is to follow patients with functional adrenal tumors during the time before and after their surgery. The main questions it aims to answer are: * What heart and blood pres...
Eligibility Criteria
Inclusion
- Patients diagnosed in the Department of Urology, Peking University First Hospital with pheochromocytoma and paraganglioma (PPGL), primary aldosteronism (PA), or Cushing syndrome (CS);
- Written informed consent obtained.
Exclusion
- Patients with PPGL, PA, or CS who receive medication or conservative treatment and are not eligible for surgical resection;
- Patients with communication disorders or severe physical impairments such as aphasia, or visual/hearing disabilities;
- Patients with severe mental illness who cannot cooperate with the study;
- Pregnant women or patients otherwise deemed unsuitable for participation by the investigators.
Key Trial Info
Start Date :
September 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 29 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07182175
Start Date
September 19 2024
End Date
May 29 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, China